Why did MAK.DE stock spike intraday today?

The spike was driven by a sharp volume surge (2,580 vs avg 646) and low float dynamics on XETRA. Retail buying amplified small orders, producing the 231.49% intraday move.

What are the major risks for MAK.DE stock investors?

Major risks include a weak current ratio (0.22), negative shareholders equity per share (-3.22), and continued operating losses (EPS -0.64). Funding or reimbursement shocks would raise downside risk.

What does Meyka AI forecast for MAK.DE stock?

Meyka AI's forecast model projects a 12-month value of €0.59 and monthly €0.74, implying an 80.33% downside from today’s €3.00. Forecasts are model-based and not guarantees.

Should traders buy MAK.DE stock after the rally?

Intraday traders can trade the momentum but should use tight stops: technicals are overbought (RSI 97.64). Long-term investors should await earnings and balance-sheet improvement before adding exposure.

DE Stocks

Maternus-Kliniken AG (MAK.DE) up 231% intraday on XETRA 24 Mar 2026: monitor volume spike

ByHuzaifa Zahoor March 24, 2026

MAK.DE stock jumped 231.49% intraday on XETRA on 24 Mar 2026, trading at €3.00 after opening at €3.80 and hitting a day low of €2.50. Volume surged to 2,580 shares versus an average of 646, a relative volume of 38.74 that explains the price spike. The move follows heightened retail interest and thin free float dynamics for Maternus-Kliniken AG on the Germany market. Meyka AI’s real-time tools flagged the rhythm of trades and technical overbought signals that traders should weigh when assessing the short-term outlook.